A cardiometabolic risk phenotype index integrating insulin resistance, systemic inflammation, and psychological burden for mortality risk stratification in metabolic dysfunction-associated steatotic liver disease: an exploratory longitudinal analysis of a nationally representative cohort
Sep 2026· Lipids in Health and Disease· Vol 25· 0 citations· 47 references
Medicine
TL;DR
The ISP index was positively associated with the risks of ACM and CVM among individuals with MASLD, but because it was constructed and internally evaluated within the same sample, its apparent predictive performance may be optimistic owing to overfitting.
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) is being increasingly recognized as a systemic cardiometabolic disorder rather than a liver-limited condition. However, the combined association of insulin resistance, systemic inflammation, and depressive symptoms with mortality remains unclear. Therefore, we developed an insulin resistance-systemic inflammation-psychological burden (ISP) index to evaluate its associations with all-cause mortality (ACM) and cardiovascular mortality (CVM). We analyzed data from 3,187 adults with MASLD in the 2005–2018 National Health and Nutrition Examination Survey. A random forest model based on mean decrease in accuracy was used to select representative markers from six insulin resistance surrogates and five systemic inflammation indices, which were combined with the PHQ-9 score to construct the ISP index. Weighted Kaplan–Meier and Cox analyses, restricted cubic splines, subgroup and sensitivity analyses, and interpretable machine learning with 5-fold cross-validation were performed. During a median 8.25-year follow-up, 382 deaths occurred, including 114 cardiovascular deaths. The metabolic score for insulin resistance (METS-IR) and systemic inflammation response index (SIRI) were selected and combined with the PHQ-9 score to construct the ISP index. In fully adjusted Cox models, the highest ISP tertile was associated with higher risks of both ACM (HR = 1.63, 95% CI: 1.12–2.38) and CVM (HR = 2.88, 95% CI: 1.36‒6.10) compared with the lowest tertile. Eight ISP-based machine-learning models were internally evaluated using 5-fold cross-validation, with the GBM model yielding 10-year AUCs of 0.869 for ACM and 0.883 for CVM. SHAP analysis of the GBM model revealed that the ISP index ranked second in feature importance after age. The ISP index was positively associated with the risks of ACM and CVM among individuals with MASLD. However, because the ISP index was constructed and internally evaluated within the same sample, its apparent predictive performance may be optimistic owing to overfitting. Therefore, the ISP index requires external validation in larger, independent prospective cohorts.
ROC curve analysis revealed that TyG-MLR displayed superior predictive performance for all-cause and cardiovascular mortality at 1, 3, and 5-year follow-ups, whereas TyG-lgSII emerged as the most accurate predictor for diabetes-related mortality.
Fei Jiang, Tian-Yi Chen, Jia-Qi Zhang et al.· Clinical and Experimental Me...· 0 citations
Composite indices integrating insulin resistance and adiposity may improve mortality risk stratification in metabolic dysfunction-associated steatotic liver disease (MASLD). We evaluated eight triglyceride-glucose (TyG)-related indices in 6,159 U.S. adults with MASLD from the 1999–2018 National Health and Nutrition E...
Kai Zhang, Na-Ni Long, Long-Hao Zhang et al.· Scientific Reports· 0 citations
Cardiovascular disease (CVD) is a major cause of excess mortality among patients with rheumatoid arthritis (RA). Conventional risk assessment may not fully capture the metabolic abnormalities and physiological vulnerability associated with RA. We investigated whether the triglyceride-glucose–frailty index (TyG-FI), whi...
Yang-Yu Xu, Hong Zhao, Yu-Xiang Gao et al.· Medicine· 0 citations
Lean MASLD shared a broadly similar cardiometabolic risk structure with Obese MASLD, whereas the relative contribution of risk factors differed between phenotypes, providing exploratory evidence of phenotype-specific metabolic associations requiring validation before clinical application.
H. Kawamura, Kei Fujiwara, Ryo Sato et al.· Hepatology Research· 0 citations
BACKGROUND
The cardiometabolic index (CMI), a composite marker derived from the product of waist-to-height ratio and triglyceride-to- high-density lipoprotein cholesterol ratio, has emerged as a potential indicator of metabolic risk. However, the prognostic value of the CMI across diverse populations and the continuum...
Zhen-Yu Liu, Zhi-Xin Li, Si-Yan Huo et al.· Heart, Lung and Circulation· 0 citations
Higher TyG and SUA levels, particularly their co-occurrence, were associated with prevalent advanced CKM, suggesting these biomarkers may characterize distinct but overlapping metabolic profiles relevant to CKM assessment.
Sheng-Zhu Huang, Jing-Wei Lin, Ling-Yu Ye et al.· Frontiers in Nutrition· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.